Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: Interleukin-8 is not the main chemotactic factor present in nasal lavages

Clinical and Experimental Allergy

Volumn 27, Issue 4, 1997, Pages 379-388

  Gosset, P ^a   Tillie Leblond, I ^a   Malaquin, F ^a   Durieu, J ^a   Wallaert, B ^a   Tonnel, A B ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Allergic rhinitis; Eosinophils; Interleukin 8; Neutrophils

Indexed keywords

ALLERGEN; CHEMOTACTIC FACTOR; INTERLEUKIN 8;

ADULT; ALLERGIC RHINITIS; ARTICLE; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; LAVAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0030935463     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb00722.x     Document Type: Article

References (26)

1. Varney VA, Jacobson MR, Sudderick RM et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Am Rev Respir Dis 1992; 146:170-6.
2. Bascom R, Pipkorn U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge: effect of corticosteroid pretreatment. Am Rev Respir Dis 1988; 138:406-12.
3. Bascom R, Wachs M, Naclerio RM et al. Basophil influx occurs after nasal antigen challenge: effect of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988; 81:580-9.
4. Pipkorn U, Proud D, Lichtenstein ML et al. Effect of short term systemic glucocorticosteroids treatment on human nasal mediator release after antigen challenge. J Clin Invest 1987; 80:957-61.
5. Cosset P, Malaquin F, Delneste Y et al. Interleukin-6 and interleukin-1α production is associated with antigen-induced late nasal response. J Allergy Clin Immunol 1993; 92:878-90.
6. Sim TC, Grant JA, Hilsmeier KA, Fukuda Y, Alam R. Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med 1994; 149:339-44.
7. Lindley I, Aschauer H, Seifert JM et al. Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. Proc Natl Acad Sci 1988; 85:9199-205.
8. Schröder JM. The neutrophil-activating peptide (NAP-1/interleukin 8), a novel cytokine of the β-thromboglobulin supergene family. In: Sorg C, ed. Natural resistance to infection, Vol. 6. Stuttgart: Gustav Fischer Verlag, 1990:50-60.
9. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989; 243:1464-8.
10. Leonard EJ, Skeel A, Yoshimura T et al. Leukocyte specificity and binding of human neutrophil attractant/activator protein-1. J. Immunol 1991; 144:1323-30.
11. Warringa RAJ, Koenderman L, Kok PTM, Kreukniet J, Bruijnzeel LB. Modulation and induction of eosinophil chemo'taxis by granulocyte-macrophage colony-stimulating factor and interleukin-3. Blood 1991; 77:2694-700.
12. White MV, Yoshumira T, Hook W, Kaliner MA, Leonard EJ. Neutrophil attractant/activation protein-1 (NAP-1) causes human basophil histamine release. Immunology Letters 1989; 22:151-6.
13. Dahinden CA, Kurimoto Y, De Weck AL et al. The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils. J Exp Med 1989; 170:1787-94.
14. Naclerio RM, Meier HL, Kagey-Sobotka A et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983; 128:597-602.
15. Lebel B, Bousquet J, Morel A, Chanal I, Godard P, Michel FB. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grasspollen grains. J Allergy Clin Immunol 1988; 82:869-77.
16. Boyüm A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Invest 1968; 21:77-83.
17. Gosset P, Tonnel AB, Joseph M et al. Secretion of a chemotactic factor for neutrophils and eosinophils by alveolar macrophages from asthmatic patients. J Allergy Clin Immunol 1984; 74:827-34.
18. Teran LM, Caroll M, Campos MG et al. Increased levels of Interleukin-8 in the BAL fluid of asthmatics 5 hours after non specific and specific antigen challenge. Am J Respir Crit Care Med 1994; 149:A952.
19. Möller A, Lippert U, Lessmann D et al. Human mast cells produce IL-8. J Immunol 1993; 151:3261-6.
20. Castells M, Schwartz LB. Tryptase levels in nasal-lavage fluid as an indicator of the immediate allergic response. J Allergy Clin Immunol. 1988; 82:348-55.
21. Standiford TJ, Kunkel SL, Basha MA et al. Interleukin-8 gene expression by a pulmonary epithelial cell line. J Clin Invest 1990; 86:1945-53.
22. Bellini A, Yoshimura H, Vittori F, Marini M, Mattoli S. Bronchial epithelial cells of patients with asthma release chemoattractant factor for T lymphocytes. J Allergy Clin Immunol 1993; 92:412-24.
23. Marini M, Vittori E, Hollemborg J, Mattoli S. Expression of the potent inflammatory cytokines granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8 in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992; 89:1001-9.
24. Stricter RM, Kasahara K, Allen R et al. Human neutrophils exhibit disparate chemotactic factor gene expression. Biochem Biophys Res Commun 1991; 173:725-31.
25. Braun RK, Franchini M, Erard F et al. Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium-ionophore. Eur J Immunol 1993; 23:956-60
26. Kuna P, Reddigari SR, Kornfeld D, Kaplan AP. IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors connective tissue activating peptide III, and interleukin-3. J Immunol 1991; 147:1920-5.